Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | selumetinib:BRD-A02303741 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.065 | 0.07 |
mRNA | PD173074 | GDSC1000 | pan-cancer | AAC | 0.064 | 0.07 |
mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | -0.096 | 0.07 |
mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.07 |
mRNA | Sunitinib | GDSC1000 | pan-cancer | AAC | -0.092 | 0.07 |
mRNA | CCT007093 | GDSC1000 | pan-cancer | AAC | -0.061 | 0.07 |
mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.07 |
mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.053 | 0.07 |
mRNA | avicin D | CTRPv2 | pan-cancer | AAC | -0.099 | 0.08 |
mRNA | Midostaurin | GDSC1000 | pan-cancer | AAC | 0.061 | 0.08 |